Amazon Pharmacy Launches GLP-1 Medications Delivery for Medicare Beneficiaries
Amazon Pharmacy introduces a $50/month delivery service for GLP-1 weight management meds under Medicare, boosting access and convenience for beneficiaries.
Major 2026 Medicare and FDA Regulatory Changes Impacting Healthcare
Discover critical 2026 regulatory changes by CMS and FDA that will impact reimbursement, prescribing practices, and patient care throughout healthcare specialties.
New CMS Rule Aims to Streamline Prior Authorization for Drugs
Discover how CMS's new rule addresses prior authorization delays, improving access to medications and streamlining the healthcare process under federal programs.
RAPID Pathway: Transforming Medicare Coverage for Breakthrough Devices
Discover how the RAPID pathway streamlines Medicare coverage for breakthrough devices, improving access and accelerating reimbursement processes.
Expedited Medicare Coverage for Breakthrough Devices via RAPID Pathway
Learn about the RAPID pathway that expedites Medicare coverage for breakthrough devices, streamlining the approval process between FDA authorization and Medicare coverage.
Streamlined Medicare Access to Breakthrough Devices through RAPID Pathway
Discover how the RAPID coverage pathway improves Medicare access to Breakthrough Devices, enhancing collaboration between CMS and the FDA for effective treatment.
Legislative Updates on Healthcare Policies and Insurance Reforms
Explore recent legislative updates affecting healthcare policies, insurance regulations, and initiatives aimed at enhancing fraud prevention and accessibility in health services.
2025 Year-End U.S. Healthcare and Insurance Regulatory Update
Key regulatory and legislative developments shaping U.S. healthcare and insurance in late 2025, including APTC expirations, CMS innovations, FDA initiatives, and congressional healthcare policy efforts.
Federal Rescheduling of Cannabis and Medicare Pilot Coverage Poised to Transform U.S. Healthcare and Investment
Federal rescheduling of cannabis to Schedule III and a Medicare pilot program are set to advance U.S. healthcare integration, research, and institutional investment in cannabis-derived products.
CMS and FDA Launch ACCESS and TEMPO to Expand Tech-Enabled Medicare Care
CMS and FDA announce ACCESS and TEMPO initiatives to expand technology-enabled care for Medicare beneficiaries with chronic conditions, focusing on outcomes-based payments and regulatory enforcement discretion.